341 related articles for article (PubMed ID: 24090962)
1. Neuroprotective effects of swimming training in a mouse model of Parkinson's disease induced by 6-hydroxydopamine.
Goes AT; Souza LC; Filho CB; Del Fabbro L; De Gomes MG; Boeira SP; Jesse CR
Neuroscience; 2014 Jan; 256():61-71. PubMed ID: 24090962
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of hesperidin in a model of Parkinson's disease induced by 6-hydroxydopamine in aged mice.
Antunes MS; Goes AT; Boeira SP; Prigol M; Jesse CR
Nutrition; 2014; 30(11-12):1415-22. PubMed ID: 25280422
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress mediated neuronal damage in the corpus striatum of 6-hydroxydopamine lesioned Parkinson's rats: neuroprotection by serotonin, GABA and bone marrow cells supplementation.
Kuruvilla KP; Nandhu MS; Paul J; Paulose CS
J Neurol Sci; 2013 Aug; 331(1-2):31-7. PubMed ID: 23726276
[TBL] [Abstract][Full Text] [Related]
4. Short-term atrazine exposure causes behavioral deficits and disrupts monoaminergic systems in male C57BL/6 mice.
Lin Z; Dodd CA; Filipov NM
Neurotoxicol Teratol; 2013; 39():26-35. PubMed ID: 23770127
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Src tyrosine kinase activity by squamosamide derivative FLZ attenuates neuroinflammation in both in vivo and in vitro Parkinson's disease models.
Tai W; Ye X; Bao X; Zhao B; Wang X; Zhang D
Neuropharmacology; 2013 Dec; 75():201-12. PubMed ID: 23916477
[TBL] [Abstract][Full Text] [Related]
6. Antidepressant-like responses in the forced swimming test elicited by glutathione and redox modulation.
Rosa JM; Dafre AL; Rodrigues AL
Behav Brain Res; 2013 Sep; 253():165-72. PubMed ID: 23850355
[TBL] [Abstract][Full Text] [Related]
7. Striatal 6-OHDA lesion in mice: Investigating early neurochemical changes underlying Parkinson's disease.
Branchi I; D'Andrea I; Armida M; Carnevale D; Ajmone-Cat MA; Pèzzola A; Potenza RL; Morgese MG; Cassano T; Minghetti L; Popoli P; Alleva E
Behav Brain Res; 2010 Mar; 208(1):137-43. PubMed ID: 19914295
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease.
Khan MM; Ahmad A; Ishrat T; Khan MB; Hoda MN; Khuwaja G; Raza SS; Khan A; Javed H; Vaibhav K; Islam F
Brain Res; 2010 Apr; 1328():139-51. PubMed ID: 20167206
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and alpha-synuclein-deleted mice.
Alvarez-Fischer D; Henze C; Strenzke C; Westrich J; Ferger B; Höglinger GU; Oertel WH; Hartmann A
Exp Neurol; 2008 Mar; 210(1):182-93. PubMed ID: 18053987
[TBL] [Abstract][Full Text] [Related]
10. Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences.
Ahmad M; Saleem S; Ahmad AS; Yousuf S; Ansari MA; Khan MB; Ishrat T; Chaturvedi RK; Agrawal AK; Islam F
J Neurochem; 2005 Apr; 93(1):94-104. PubMed ID: 15773909
[TBL] [Abstract][Full Text] [Related]
11. Induction of depressive-like behavior by intranigral 6-OHDA is directly correlated with deficits in striatal dopamine and hippocampal serotonin.
Santiago RM; Barbiero J; Gradowski RW; Bochen S; Lima MM; Da Cunha C; Andreatini R; Vital MA
Behav Brain Res; 2014 Feb; 259():70-7. PubMed ID: 24183944
[TBL] [Abstract][Full Text] [Related]
12. Attenuation by Nardostachys jatamansi of 6-hydroxydopamine-induced parkinsonism in rats: behavioral, neurochemical, and immunohistochemical studies.
Ahmad M; Yousuf S; Khan MB; Hoda MN; Ahmad AS; Ansari MA; Ishrat T; Agrawal AK; Islam F
Pharmacol Biochem Behav; 2006 Jan; 83(1):150-60. PubMed ID: 16500697
[TBL] [Abstract][Full Text] [Related]
13. Impaired acquisition of skilled behavior in rotarod task by moderate depletion of striatal dopamine in a pre-symptomatic stage model of Parkinson's disease.
Ogura T; Ogata M; Akita H; Jitsuki S; Akiba L; Noda K; Hoka S; Saji M
Neurosci Res; 2005 Mar; 51(3):299-308. PubMed ID: 15710494
[TBL] [Abstract][Full Text] [Related]
14. Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28.
Youdim MB; Stephenson G; Ben Shachar D
Ann N Y Acad Sci; 2004 Mar; 1012():306-25. PubMed ID: 15105275
[TBL] [Abstract][Full Text] [Related]
15. Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine.
Santiago RM; Barbieiro J; Lima MM; Dombrowski PA; Andreatini R; Vital MA
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1104-14. PubMed ID: 20547199
[TBL] [Abstract][Full Text] [Related]
16. PPAR-α agonist fenofibrate protects against the damaging effects of MPTP in a rat model of Parkinson's disease.
Barbiero JK; Santiago R; Tonin FS; Boschen S; da Silva LM; Werner MF; da Cunha C; Lima MM; Vital MA
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Aug; 53():35-44. PubMed ID: 24593945
[TBL] [Abstract][Full Text] [Related]
17. Withania somnifera root extract improves catecholamines and physiological abnormalities seen in a Parkinson's disease model mouse.
RajaSankar S; Manivasagam T; Sankar V; Prakash S; Muthusamy R; Krishnamurti A; Surendran S
J Ethnopharmacol; 2009 Sep; 125(3):369-73. PubMed ID: 19666100
[TBL] [Abstract][Full Text] [Related]
18. Physical training prevents depressive symptoms and a decrease in brain-derived neurotrophic factor in Parkinson's disease.
Tuon T; Valvassori SS; Dal Pont GC; Paganini CS; Pozzi BG; Luciano TF; Souza PS; Quevedo J; Souza CT; Pinho RA
Brain Res Bull; 2014 Sep; 108():106-12. PubMed ID: 25264157
[TBL] [Abstract][Full Text] [Related]
19. Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice.
Iancu R; Mohapel P; Brundin P; Paul G
Behav Brain Res; 2005 Jul; 162(1):1-10. PubMed ID: 15922062
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effect of sesame seed oil in 6-hydroxydopamine induced neurotoxicity in mice model: cellular, biochemical and neurochemical evidence.
Ahmad S; Khan MB; Hoda MN; Bhatia K; Haque R; Fazili IS; Jamal A; Khan JS; Katare DP
Neurochem Res; 2012 Mar; 37(3):516-26. PubMed ID: 22089932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
